Middle East & Africa Nuclear Medicine Market Size & Outlook
Middle East & Africa nuclear medicine market, 2018-2030 (US$M)
Related Markets
MEA nuclear medicine market highlights
- The MEA nuclear medicine market generated a revenue of USD 359.0 million in 2023.
- The market is expected to grow at a CAGR of 8% from 2024 to 2030.
- In terms of segment, diagnostics was the largest revenue generating product in 2023.
- Therapeutics is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, South Africa is expected to register the highest CAGR from 2024 to 2030.
MEA data book summary
| Market revenue in 2023 | USD 359.0 million |
| Market revenue in 2030 | USD 613.3 million |
| Growth rate | 8% (CAGR from 2023 to 2030) |
| Largest segment | Diagnostics |
| Fastest growing segment | Therapeutics |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Diagnostics, Therapeutics |
| Key market players worldwide | GE HealthCare Technologies Inc Common Stock, Jubilant Pharmova, Nordion, Bracco, Iren SpA, Abliva AB, Lantheus Holdings Inc, Eckert & Ziegler Bebig SA, Mallinckrodt PLC Ordinary Shares - New, Cardinal Health Inc |
Other key industry trends
- In terms of revenue, MEA region accounted for 3.5% of the global nuclear medicine market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- North America is the fastest growing regional market and is projected to reach USD 11,566.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Nuclear Medicine Market Scope
Nuclear Medicine Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Middle East & Africa nuclear medicine market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to nuclear medicine market will help companies and investors design strategic landscapes.
Diagnostics was the largest segment with a revenue share of 76.21% in 2023. Horizon Databook has segmented the Middle East & Africa nuclear medicine market based on diagnostics, therapeutics covering the revenue growth of each sub-segment from 2018 to 2030.
In 2018, IAEA started a 4-year project to help 17 African countries to produce and use radiopharmaceuticals for the treatment & management of cancer and other common diseases. Egypt, Israel, Turkey, and Saudi Arabia are the only countries in MEA that have production facilities of Mo99 and can convert Mo-99 to Tc-99. Other countries in this region import radioisotopes or cold kits to meet consumer demand.
The most commonly used radioisotopes in this region are Tc-99 and I-131. In addition, increasing availability of Ga-68 generators is expected to increase the use of PET scans. On the other hand, the most widely used therapeutic radioisotopes include Lu-177, Y-90, Re-188, I-131, and Sr-89. Nuclear medicine has major potential in treating cancer and cardiovascular disease.
Consequently, such diseases are crucial factors for market growth. For instance, according to a study by the Abu Dhabi Health Department in 2018, annually, there approximately 4,500 new cancer cases in the UAE. Moreover, WHO stated that in the Middle East, including the UAE, cancer cases are estimated to double by 2030. All these factors are expected to propel market growth.
Reasons to subscribe to Middle East & Africa nuclear medicine market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Middle East & Africa nuclear medicine market databook
-
Our clientele includes a mix of nuclear medicine market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa nuclear medicine market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa nuclear medicine market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
MEA nuclear medicine market size, by country, 2018-2030 (US$M)
Middle East & Africa Nuclear Medicine Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
